Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel T Chang
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bc Cancer Agency
Vancouver, British Columbia, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Ucla
Los Angeles, California, United States
- Ucsf
San Francisco, California, United States
- Stanford University, School of Medicine
Stanford, California, United States
- Loyola University
Maywood, Illinois, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Swedish Cancer Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Aug 2013
- Primary completion
- 30 Sept 2021
- Completion
- 30 Sept 2022
- Last update posted
- 28 Oct 2022
- Registered enrollment
- 27
- Registry id
- NCT01926197
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.